Correction: Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trial.
Saved in:
| Title: | Correction: Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trial. |
|---|---|
| Authors: | Cai, Lin1 (AUTHOR), Li, Chengxin2 (AUTHOR), Li, Shanshan3 (AUTHOR), Zhang, Xiaodong4 (AUTHOR), Wang, Gang5 (AUTHOR), Yu, Jianbin6 (AUTHOR), Huang, Kun7 (AUTHOR), Fang, Hong8 (AUTHOR), Ding, Yangfeng9 (AUTHOR), Wang, Jinyan10 (AUTHOR), Jiang, Congjun11 (AUTHOR), Lu, Qianjin12 (AUTHOR), Tao, Juan13 (AUTHOR), Zhang, Jianzhong1 (AUTHOR) rmzjz@126.com |
| Source: | Dermatology & Therapy. Oct2025, Vol. 15 Issue 10, p2817-2818. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-025-01480-5 |
